S&P 500   4,283.85 (+0.24%)
DOW   33,573.28 (+0.03%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.88 (+2.74%)
BABA   86.70 (+2.73%)
AMD   124.37 (+5.46%)
T   15.67 (+1.82%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.57%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
S&P 500   4,283.85 (+0.24%)
DOW   33,573.28 (+0.03%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.88 (+2.74%)
BABA   86.70 (+2.73%)
AMD   124.37 (+5.46%)
T   15.67 (+1.82%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.57%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
S&P 500   4,283.85 (+0.24%)
DOW   33,573.28 (+0.03%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.88 (+2.74%)
BABA   86.70 (+2.73%)
AMD   124.37 (+5.46%)
T   15.67 (+1.82%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.57%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
S&P 500   4,283.85 (+0.24%)
DOW   33,573.28 (+0.03%)
QQQ   354.84 (-0.02%)
AAPL   179.21 (-0.21%)
MSFT   333.68 (-0.67%)
META   271.12 (-0.10%)
GOOGL   127.31 (+1.03%)
AMZN   126.61 (+1.05%)
TSLA   221.31 (+1.70%)
NVDA   386.54 (-1.32%)
NIO   7.88 (+2.74%)
BABA   86.70 (+2.73%)
AMD   124.37 (+5.46%)
T   15.67 (+1.82%)
F   12.93 (+2.70%)
MU   67.54 (-0.34%)
CGC   0.74 (-5.57%)
GE   105.46 (+1.31%)
DIS   92.16 (+1.27%)
AMC   4.64 (+0.22%)
PFE   38.37 (-0.72%)
PYPL   65.02 (+0.79%)
NFLX   399.29 (-1.05%)
NYSE:FMS

Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

$22.27
+0.35 (+1.60%)
(As of 04:00 PM ET)
Compare
Today's Range
$22.08
▼
$22.28
50-Day Range
$20.64
▼
$24.54
52-Week Range
$12.78
▼
$29.14
Volume
309,634 shs
Average Volume
795,164 shs
Market Capitalization
$13.07 billion
P/E Ratio
21.01
Dividend Yield
1.89%
Price Target
$28.45
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media

FMS vs. AGL, DVA, SHC, PGNY, SNN, TECH, PEN, SRPT, INCY, and AVTR

Should you be buying Fresenius Medical Care AG & Co. KGaA stock or one of its competitors? The main competitors of Fresenius Medical Care AG & Co. KGaA include agilon health (AGL), DaVita (DVA), Sotera Health (SHC), Progyny (PGNY), Smith & Nephew (SNN), Bio-Techne (TECH), Penumbra (PEN), Sarepta Therapeutics (SRPT), Incyte (INCY), and Avantor (AVTR). These companies are all part of the "medical" sector.

Fresenius Medical Care AG & Co. KGaA vs.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and agilon health (NYSE:AGL) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment, community ranking and earnings.

5.6% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 3.3% of agilon health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has a net margin of 3.06% compared to agilon health's net margin of -2.88%. Fresenius Medical Care AG & Co. KGaA's return on equity of 5.44% beat agilon health's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA 3.06% 5.44% 2.35%
agilon health -2.88% -7.98% -4.54%

Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $28.45, suggesting a potential upside of 28.21%. agilon health has a consensus price target of $31.13, suggesting a potential upside of 51.17%. Given agilon health's stronger consensus rating and higher possible upside, analysts plainly believe agilon health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
2 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.78
agilon health
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than agilon health. agilon health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$20.44 billion0.64$709.50 million$1.0620.93
agilon health$2.71 billion3.17-$106.55 million-$0.22-94.05

In the previous week, agilon health had 2 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 5 mentions for agilon health and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.33 beat agilon health's score of 0.48 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
agilon health
1 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Fresenius Medical Care AG & Co. KGaA received 348 more outperform votes than agilon health when rated by MarketBeat users. However, 60.32% of users gave agilon health an outperform vote while only 53.46% of users gave Fresenius Medical Care AG & Co. KGaA an outperform vote.

CompanyUnderperformOutperform
Fresenius Medical Care AG & Co. KGaAOutperform Votes
386
53.46%
Underperform Votes
336
46.54%
agilon healthOutperform Votes
38
60.32%
Underperform Votes
25
39.68%

Fresenius Medical Care AG & Co. KGaA has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500. Comparatively, agilon health has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500.

Summary

Fresenius Medical Care AG & Co. KGaA beats agilon health on 10 of the 18 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FMS vs. The Competition

Export to Excel
MetricFresenius Medical Care AG & Co. KGaAhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE Exchange
Market Cap$13.02B$2.59B$4.53B$14.77B
Dividend Yield1.90%1.90%5.98%3.97%
P/E Ratio20.9313.9192.3718.18
Price / Sales0.6415.693,450.549.00
Price / Cash4.4224.0822.3115.62
Price / Book0.804.424.707.00
Net Income$709.50M$55.08M$116.38M$896.30M
7 Day Performance3.31%2.43%4.26%3.33%
1 Month Performance-5.25%2.69%2.10%2.41%
1 Year Performance-22.74%-25.19%15.17%-7.58%

Fresenius Medical Care AG & Co. KGaA Competitors List

Export to Excel
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AGL
agilon health
1.6537 of 5 stars		$20.25
-0.1%		$31.13
+53.7%		+5.7%$8.40B$2.71B-92.02646
DVA
DaVita
2.4051 of 5 stars		$92.42
-2.0%		$96.88
+4.8%		+2.5%$8.38B$11.61B17.0570,000
SHC
Sotera Health
1.7614 of 5 stars		$14.04
-2.0%		$16.50
+17.5%		-31.8%$3.97B$1.00B-15.103,000Positive News
PGNY
Progyny
2.4106 of 5 stars		$37.23
-0.4%		$48.86
+31.2%		+30.0%$3.51B$873.09M86.58311Insider Selling
SNN
Smith & Nephew
1.6728 of 5 stars		$29.98
-0.3%		N/A-4.0%$13.09B$5.22B0.0019,012News Coverage
TECH
Bio-Techne
2.7939 of 5 stars		$83.18
-0.4%		$104.45
+25.6%		-8.9%$13.10B$1.11B49.813,000
PEN
Penumbra
1.9562 of 5 stars		$310.72
+1.4%		$296.33
-4.6%		+128.2%$11.89B$847.13M1,942.123,900Analyst Report
Insider Selling
SRPT
Sarepta Therapeutics
2.7189 of 5 stars		$124.82
-1.6%		$169.65
+35.9%		+72.9%$11.63B$933.01M-9.841,162
INCY
Incyte
3.0758 of 5 stars		$61.87
-1.1%		$81.50
+31.7%		-15.7%$13.80B$3.47B42.672,324
AVTR
Avantor
2.6768 of 5 stars		$20.58
-0.3%		$28.75
+39.7%		-38.1%$13.89B$7.51B22.3714,500

Related Companies and Tools

Related Companies:
Top 10 Stock Comparisons
This page (NYSE:FMS) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -